Elrayess, R.; Abdel Aziz, Y.M.; Elgawish, M.S.; Elewa, M.; Yassen, A.S.A.; Elhady, S.S.; Elshihawy, H.A.; Said, M.M.
Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals 2021, 14, 9.
https://doi.org/10.3390/ph14010009
AMA Style
Elrayess R, Abdel Aziz YM, Elgawish MS, Elewa M, Yassen ASA, Elhady SS, Elshihawy HA, Said MM.
Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals. 2021; 14(1):9.
https://doi.org/10.3390/ph14010009
Chicago/Turabian Style
Elrayess, Ranza, Yasmine M. Abdel Aziz, Mohamed Saleh Elgawish, Marwa Elewa, Asmaa S. A. Yassen, Sameh S. Elhady, Hosam A. Elshihawy, and Mohamed M. Said.
2021. "Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line" Pharmaceuticals 14, no. 1: 9.
https://doi.org/10.3390/ph14010009
APA Style
Elrayess, R., Abdel Aziz, Y. M., Elgawish, M. S., Elewa, M., Yassen, A. S. A., Elhady, S. S., Elshihawy, H. A., & Said, M. M.
(2021). Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals, 14(1), 9.
https://doi.org/10.3390/ph14010009